Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Retinal Arteriolar Abnormalities and CV Mortality

This study has been completed.
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00011167
First received: February 13, 2001
Last updated: February 5, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2003
  Primary Completion Date: February 2003 (Final data collection date for primary outcome measure)